Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page
- CheckyesterdayChange DetectedSite version updated from v3.4.2 to v3.4.3; no visible changes to study details or page content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedOnly the site’s revision label was updated from v3.4.1 to v3.4.2; there are no visible changes to the page content or features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision numbers on the page were updated: added v3.4.1 and removed v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedThe site updated from version v3.4.0 to v3.4.1; no visible changes to study details or layout are evident.SummaryDifference0.0%

- Check52 days agoChange DetectedPage footer revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded a centralized Locations section listing study sites across the United States and Canada (Alabama, California, North Carolina, Alberta, British Columbia, Ontario, Saskatchewan) and removed the older per-location pages (e.g., Alabama Locations) and the HHS Vulnerability Disclosure link.SummaryDifference0.7%

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.